Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026)

Johnson & Johnson has disclosed Accounts Payables across 18 years of filings, most recently posting $9.2 billion for Q2 2026.

• In Q2 2026, Accounts Payables fell 2.55% year-over-year to $9.2 billion; the TTM figure through Jun 2026 stood at $9.2 billion (down 2.55% YoY), while the FY2025 annual figure was $12.0 billion, up 16.29% from the prior year.
• Accounts Payables came in at $9.2 billion for Q2 2026 at Johnson & Johnson, down from $10.5 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $12.0 billion in Q4 2025 to a low of $8.2 billion in Q1 2024.
• Average Accounts Payables over 5 years is $9.7 billion, with a median of $9.6 billion recorded in 2023.
• Year-over-year, Accounts Payables retreated 17.71% in 2023 and increased 16.77% in 2025.
• Over 5 years, Accounts Payables stood at $10.2 billion in 2022, then retreated by 5.13% to $9.6 billion in 2023, then increased by 7.05% to $10.3 billion in 2024, then gained by 16.29% to $12.0 billion in 2025, then dropped by 23.08% to $9.2 billion in 2026.
• Per Business Quant data, the three most recent Accounts Payables figures were $9.2 billion in Q2 2026, $10.5 billion in Q1 2026, and $12.0 billion in Q4 2025.